Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 114
10
Diseases
10
Unique genes
0.360
Avg. similarity score
Amyloid neuropathy
Most-connected disease (7 links)
Disease
Searched: cerebral amyloid angiopathy, app-related
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
cerebral amyloid angiopathy, app-related
Amyloid neuropathy
Abeta amyloidosis
Amyloid angiopathy
Eye manifestations
Partial epilepsy with variable foci
Acne inversa
Early onset alzheimers disease with behavioral disturbance
Dowling degos disease
Pash syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Amyloid neuropathy | 7 | 7 | 3 |
| Abeta amyloidosis | 5 | 5 | 1 |
| Amyloid angiopathy | 5 | 5 | 1 |
| Eye manifestations | 5 | 5 | 1 |
| Partial epilepsy with variable foci | 5 | 5 | 1 |
| cerebral amyloid angiopathy, app-related | 5 | 5 | 1 |
| Acne inversa | 4 | 4 | 3 |
| Early onset alzheimers disease with behavioral disturbance | 2 | 2 | 2 |
| Dowling degos disease | 1 | 1 | 5 |
| Pash syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| APP | 6 / 10 | Abeta amyloidosis, Amyloid angiopathy, Amyloid neuropathy, cerebral amyloid angiopathy, app-related and 2 more |
| PSEN1 | 3 / 10 | Acne inversa, Amyloid neuropathy, Early onset alzheimers disease with behavioral disturbance |
| NCSTN | 2 / 10 | Acne inversa, Pash syndrome |
| PSENEN | 2 / 10 | Acne inversa, Dowling degos disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| NOTCH3 Activation and Transmission of Signal to the Nucleus | Reactome | 4 / 19 | 253× | 9.34e-10 | 9.97e-8 ✓ sig. |
| Amyloid fiber formation | Reactome | 5 / 109 | 55.1× | 1.36e-8 | 1.08e-6 ✓ sig. |
| Noncanonical activation of NOTCH3 | Reactome | 3 / 8 | 450× | 2.32e-8 | 1.73e-6 ✓ sig. |
| Regulated proteolysis of p75NTR | Reactome | 3 / 11 | 328× | 6.84e-8 | 4.55e-6 ✓ sig. |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | Reactome | 4 / 58 | 82.8× | 1.01e-7 | 6.37e-6 ✓ sig. |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | Reactome | 4 / 58 | 82.8× | 1.01e-7 | 6.37e-6 ✓ sig. |
| NRIF signals cell death from the nucleus | Reactome | 3 / 15 | 240× | 1.88e-7 | 1.10e-5 ✓ sig. |
| Nuclear signaling by ERBB4 | Reactome | 3 / 24 | 150× | 8.34e-7 | 4.00e-5 ✓ sig. |
| Alzheimer disease | KEGG | 5 / 388 | 15.5× | 7.56e-6 | 2.57e-4 ✓ sig. |
| EPH-ephrin mediated repulsion of cells | Reactome | 3 / 50 | 72.1× | 7.98e-6 | 2.69e-4 ✓ sig. |
| Notch signaling pathway | KEGG | 3 / 62 | 58.1× | 1.53e-5 | 4.66e-4 ✓ sig. |
| Neutrophil degranulation | Reactome | 4 / 480 | 10.0× | 4.37e-4 | 7.09e-3 ✓ sig. |
| Other types of O-glycan biosynthesis | KEGG | 2 / 47 | 51.1× | 6.61e-4 | 9.80e-3 ✓ sig. |
| Post-translational protein phosphorylation | Reactome | 2 / 108 | 22.2× | 3.44e-3 | 3.38e-2 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 2 / 125 | 19.2× | 4.58e-3 | 4.13e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Notch signaling pathway | GO:0007219 | 6 / 117 | 95.8× | 1.09e-11 | 3.97e-9 ✓ sig. |
| amyloid precursor protein catabolic process | GO:0042987 | 4 / 14 | 534× | 4.13e-11 | 1.32e-8 ✓ sig. |
| membrane protein ectodomain proteolysis | GO:0006509 | 4 / 27 | 277× | 7.21e-10 | 1.68e-7 ✓ sig. |
| Notch receptor processing | GO:0007220 | 3 / 9 | 623× | 9.25e-9 | 1.58e-6 ✓ sig. |
| amyloid-beta formation | GO:0034205 | 3 / 10 | 561× | 1.32e-8 | 2.16e-6 ✓ sig. |
| amyloid precursor protein metabolic process | GO:0042982 | 3 / 12 | 467× | 2.42e-8 | 3.63e-6 ✓ sig. |
| protein processing | GO:0016485 | 4 / 95 | 78.7× | 1.29e-7 | 1.48e-5 ✓ sig. |
| regulation of Notch signaling pathway | GO:0008593 | 3 / 23 | 244× | 1.94e-7 | 2.11e-5 ✓ sig. |
| positive regulation of tumor necrosis factor production | GO:0032760 | 4 / 113 | 66.1× | 2.59e-7 | 2.69e-5 ✓ sig. |
| protein catabolic process at postsynapse | GO:0140249 | 2 / 3 | 1,246× | 7.73e-7 | 6.69e-5 ✓ sig. |
| astrocyte activation involved in immune response | GO:0002265 | 2 / 4 | 934× | 1.55e-6 | 1.19e-4 ✓ sig. |
| somitogenesis | GO:0001756 | 3 / 50 | 112× | 2.13e-6 | 1.53e-4 ✓ sig. |
| positive regulation of amyloid fibril formation | GO:1905908 | 2 / 5 | 747× | 2.58e-6 | 1.77e-4 ✓ sig. |
| cellular response to manganese ion | GO:0071287 | 2 / 7 | 534× | 5.40e-6 | 3.22e-4 ✓ sig. |
| learning or memory | GO:0007611 | 3 / 72 | 77.9× | 6.45e-6 | 3.72e-4 ✓ sig. |